Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...
Hosted on MSN7mon
FDA Approves Novel Nebulized Therapy for COPDThe FDA approved inhaled ensifentrine (Ohtuvayre) as maintenance treatment for chronic obstructive ... therapy acts as both a bronchodilator and non-steroidal anti-inflammatory, simultaneously ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback